The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
Kidney Cancer Research Bureau
Second Life Therapeutics
Tanabe Pharma America, Inc.
DualityBio Inc.
Maastricht University Medical Center
ModeX Therapeutics, An OPKO Health Company
TransThera Sciences (Nanjing), Inc.
NGM Biopharmaceuticals, Inc
ImmunoGenesis
UNICANCER
TransThera Sciences (Nanjing), Inc.
Evopoint Biosciences Inc.
Klus Pharma Inc.
Genmab
Kineta Inc.
Ludwig Institute for Cancer Research
Seagen Inc.
Memorial Sloan Kettering Cancer Center
Otsuka Novel Products GmbH
Memorial Sloan Kettering Cancer Center
University of Plymouth